Robertson J A, Gallagher N D
Gastroenterology. 1985 Dec;89(6):1353-9. doi: 10.1016/0016-5085(85)90655-9.
Chloroquine, which interferes with the degradation of a number of transport proteins, impedes the exit of cobalamin from the small intestine of the mouse. This study was designed to determine if treatment with the drug led to the retention of cobalamin in the form of intrinsic factor-cobalamin in the ileal mucosa. Solubilized homogenates were prepared 2-4 h after an oral dose of [57Co]cobalamin and were examined by gel chromatography. There was a progressive transfer of [57Co]cobalamin from a protein identified as intrinsic factor to transcobalamin II in control mice. In chloroquine-treated mice, the major radioactive protein peak 2-4 h after an oral dose corresponded with the position of intrinsic factor. Only a small amount of the radioactivity was associated with transcobalamin. Cobalamin binding proteins were also identified by polyacrylamide gel electrophoresis and by their reaction with specific antibodies. It is concluded that chloroquine interferes with the release of cobalamin from intrinsic factor and thus slows the release of cobalamin from the intestine.
氯喹可干扰多种转运蛋白的降解,从而阻碍钴胺素从小鼠小肠排出。本研究旨在确定用该药物治疗是否会导致钴胺素以内因子 - 钴胺素的形式保留在回肠黏膜中。口服[57Co]钴胺素后2 - 4小时制备可溶性匀浆,并通过凝胶色谱法进行检测。在对照小鼠中,[57Co]钴胺素从一种被鉴定为内因子的蛋白质逐渐转移至转钴胺素II。在用氯喹治疗的小鼠中,口服给药后2 - 4小时的主要放射性蛋白峰与内因子的位置相对应。只有少量放射性与转钴胺素相关。还通过聚丙烯酰胺凝胶电泳及其与特异性抗体的反应鉴定了钴胺素结合蛋白。得出的结论是,氯喹干扰了钴胺素从内因子的释放,从而减缓了钴胺素从肠道的释放。